208 related articles for article (PubMed ID: 22461534)
1. Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection.
Krisl JC; Taber DJ; Pilch N; Chavin K; Bratton C; Thomas B; McGillicuddy J; Baliga P
Clin J Am Soc Nephrol; 2012 Jun; 7(6):1003-9. PubMed ID: 22461534
[TBL] [Abstract][Full Text] [Related]
2. Combination of Leflunomide and Everolimus for treatment of BK virus nephropathy.
Jaw J; Hill P; Goodman D
Nephrology (Carlton); 2017 Apr; 22(4):326-329. PubMed ID: 28247521
[TBL] [Abstract][Full Text] [Related]
3. Leflunomide for polyomavirus type BK nephropathy.
Williams JW; Javaid B; Kadambi PV; Gillen D; Harland R; Thistlewaite JR; Garfinkel M; Foster P; Atwood W; Millis JM; Meehan SM; Josephson MA
N Engl J Med; 2005 Mar; 352(11):1157-8. PubMed ID: 15784677
[No Abstract] [Full Text] [Related]
4. Efficacy of Intravenous Immunoglobulin in the Treatment of Persistent BK Viremia and BK Virus Nephropathy in Renal Transplant Recipients.
Shah T; Vu D; Naraghi R; Campbell A; Min D
Clin Transpl; 2014; ():109-16. PubMed ID: 26281134
[TBL] [Abstract][Full Text] [Related]
5. Active management versus minimization of immunosuppressives of BK virus-associated nephropathy after a kidney transplant.
Halim MA; Al-Otaibi T; Gheith O; Zkaria Z; Mosaad A; Said T; Nair P; Nampoory N
Exp Clin Transplant; 2014 Dec; 12(6):528-33. PubMed ID: 25489803
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Follow-Up of Active Treatment Versus Minimization of Immunosuppressive Agents in Patients With BK Virus-Associated Nephropathy After Kidney Transplant.
Halim MA; Al-Otaibi T; Gheith O; Mosaad A; Zakaria Z; Said T; Nair P; Nampoory NM
Exp Clin Transplant; 2016 Feb; 14(1):58-65. PubMed ID: 26862825
[TBL] [Abstract][Full Text] [Related]
7. Leflunomide therapy for polyomavirus-induced allograft nephropathy: efficient BK virus elimination without increased risk of rejection.
Teschner S; Gerke P; Geyer M; Wilpert J; Krumme B; Benzing T; Walz G
Transplant Proc; 2009; 41(6):2533-8. PubMed ID: 19715969
[TBL] [Abstract][Full Text] [Related]
8. Treatment of renal allograft polyoma BK virus infection with leflunomide.
Josephson MA; Gillen D; Javaid B; Kadambi P; Meehan S; Foster P; Harland R; Thistlethwaite RJ; Garfinkel M; Atwood W; Jordan J; Sadhu M; Millis MJ; Williams J
Transplantation; 2006 Mar; 81(5):704-10. PubMed ID: 16534472
[TBL] [Abstract][Full Text] [Related]
9. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
[TBL] [Abstract][Full Text] [Related]
10. Contrasting patterns of viral load response in transplant recipients with BK polyomavirus DNAemia on leflunomide therapy.
Cuellar-Rodriguez J; Stephany B; Poggio E; Mossad SB; Goldfarb D; Lard M; Askar M; Fatica R; Srinivas T; Braun W; Shoskes D; Flechner S; Schmitt SK; Shrestha R; Avery RK
Clin Transplant; 2013; 27(3):E230-6. PubMed ID: 23551281
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of leflunomide for BK polyomavirus associated nephropathy in kidney transplant recipients: A multicenter retrospective study.
Keller N; Duquennoy S; Conrad A; Fafi-Kremer S; Morelon E; Bouvier N; Moulin B; Hurault De Ligny B; Caillard S
Transpl Infect Dis; 2019 Apr; 21(2):e13058. PubMed ID: 30730102
[TBL] [Abstract][Full Text] [Related]
12. Leflunomide therapy for BK virus allograft nephropathy in pediatric and young adult kidney transplant recipients.
Araya CE; Garin EH; Neiberger RE; Dharnidharka VR
Pediatr Transplant; 2010 Feb; 14(1):145-50. PubMed ID: 19344337
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of polyomavirus BK replication and impact of preemptive immunosuppression reduction in renal-transplant recipients in China: a 5-year single-center analysis.
Huang G; Wang CX; Zhang L; Fei JG; Deng SX; Qiu J; Li J; Chen GD; Fu Q; Chen LZ
Diagn Microbiol Infect Dis; 2015 Jan; 81(1):21-6. PubMed ID: 25445121
[TBL] [Abstract][Full Text] [Related]
14. Severe crescentic BK virus nephropathy with favourable outcome in a transplanted patient treated with Leflunomide.
Mazzucco G; Costa C; Bergallo M; Segoloni GP; Monga G
Clin Nephrol; 2008 Aug; 70(2):163-7. PubMed ID: 18793533
[TBL] [Abstract][Full Text] [Related]
15. Management of BK virus nephropathy in kidney transplant recipients at the Royal Hospital - Clinical Audit - Oman.
Al-Raisi F; Mohsin N; Kamble P
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():156-8. PubMed ID: 25894146
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial.
Lee BT; Gabardi S; Grafals M; Hofmann RM; Akalin E; Aljanabi A; Mandelbrot DA; Adey DB; Heher E; Fan PY; Conte S; Dyer-Ward C; Chandraker A
Clin J Am Soc Nephrol; 2014 Mar; 9(3):583-9. PubMed ID: 24482066
[TBL] [Abstract][Full Text] [Related]
17. Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation.
Elfadawy N; Flechner SM; Schold JD; Srinivas TR; Poggio E; Fatica R; Avery R; Mossad SB
Clin J Am Soc Nephrol; 2014 Mar; 9(3):553-61. PubMed ID: 24408118
[TBL] [Abstract][Full Text] [Related]
18. The impact of surveillance and rapid reduction in immunosuppression to control BK virus-related graft injury in kidney transplantation.
Elfadawy N; Flechner SM; Liu X; Schold J; Tian D; Srinivas TR; Poggio E; Fatica R; Avery R; Mossad SB
Transpl Int; 2013 Aug; 26(8):822-32. PubMed ID: 23763289
[TBL] [Abstract][Full Text] [Related]
19. Higher levels of leflunomide are associated with hemolysis and are not superior to lower levels for BK virus clearance in renal transplant patients.
Leca N; Muczynski KA; Jefferson JA; de Boer IH; Kowalewska J; Kendrick EA; Pichler R; Davis CL
Clin J Am Soc Nephrol; 2008 May; 3(3):829-35. PubMed ID: 18372319
[TBL] [Abstract][Full Text] [Related]
20. Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.
Knight RJ; Gaber LW; Patel SJ; DeVos JM; Moore LW; Gaber AO
Transplantation; 2013 Apr; 95(7):949-54. PubMed ID: 23545506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
